Moscicki, One Of US FDA's Industry Connections, Moves To PhRMA
Executive Summary
One of the faces of FDA's effort to recruit senior leaders from outside its walls has decided to return to industry.
You may also be interested in...
US FDA Office Of New Drugs Likely To Be Headed By Deputy Director Stein
Peter Stein is a familiar face within OND and has been working alongside CDER Director Janet Woodcock on the proposed “modernization” of OND. As a previous recruit from outside FDA, Stein has had time to make the key connections and adjustments to working inside government.
Moscicki's Move From FDA To PhRMA About 'Best' Use Of Leadership Skills
At inconveniently timed NORD conference, the former CDER deputy center director finds himself unable to speak for either FDA or the Pharmaceutical Research and Manufacturers of America.
Sarepta Complained To Woodcock About Exondys 51 Review Early And Often
Documents also show that Sarepta officials begged CDER director for approval on multiple occasions prior to the agency's September 2016 decision.